Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ahmed Kandeil and Yassmin Moatasim.
Ahmed Kandeil
Connection Strength
1.969
Yassmin Moatasim
  1. Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2. Pathogens. 2021 Jun 15; 10(6).
    View in: PubMed
    Score: 0.238
  2. Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3).
    View in: PubMed
    Score: 0.233
  3. Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471.
    View in: PubMed
    Score: 0.228
  4. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour Announc. 2020 May 28; 9(22).
    View in: PubMed
    Score: 0.221
  5. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108.
    View in: PubMed
    Score: 0.201
  6. Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt. J Gen Virol. 2017 Jul; 98(7):1573-1586.
    View in: PubMed
    Score: 0.181
  7. Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses. Arch Virol. 2017 Oct; 162(10):2959-2969.
    View in: PubMed
    Score: 0.180
  8. New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2. ChemMedChem. 2021 11 19; 16(22):3418-3427.
    View in: PubMed
    Score: 0.060
  9. 3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2. Bioorg Chem. 2021 09; 114:105131.
    View in: PubMed
    Score: 0.060
  10. New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2. Bioorg Chem. 2021 09; 114:105117.
    View in: PubMed
    Score: 0.060
  11. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413.
    View in: PubMed
    Score: 0.058
  12. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
    View in: PubMed
    Score: 0.057
  13. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851.
    View in: PubMed
    Score: 0.057
  14. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739.
    View in: PubMed
    Score: 0.057
  15. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1.
    View in: PubMed
    Score: 0.044
  16. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013 Sep 05; 18(36):pii=20574.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.